Alshahrani Saeed, Rapoport Robert M, Zahedi Kamyar, Jiang Min, Nieman Michelle, Barone Sharon, Meredith Andrea L, Lorenz John N, Rubinstein Jack, Soleimani Manoocher
Department of Pharmacology and Cell Biophysics, University of Cincinnati, College of Medicine, Cincinnati, OH, United States of America.
Center on Genetics of Transport and Epithelial Biology, University of Cincinnati, Cincinnati, OH, United States of America.
PLoS One. 2017 Jul 18;12(7):e0181376. doi: 10.1371/journal.pone.0181376. eCollection 2017.
Thiazide derivatives including Hydrochlorothiazide (HCTZ) represent the most common treatment of mild to moderate hypertension. Thiazides initially enhance diuresis via inhibition of the kidney Na+-Cl- Cotransporter (NCC). However, chronic volume depletion and diuresis are minimal while lowered blood pressure (BP) is maintained on thiazides. Thus, a vasodilator action of thiazides is proposed, likely via Ca2+-activated K+ (BK) channels in vascular smooth muscles. This study ascertains the role of volume depletion induced by salt restriction or salt wasting in NCC KO mice on the non-diuretic hypotensive action of HCTZ. HCTZ (20mg/kg s.c.) lowered BP in 1) NCC KO on a salt restricted diet but not with normal diet; 2) in volume depleted but not in volume resuscitated pendrin/NCC dKO mice; the BP reduction occurs without any enhancement in salt excretion or reduction in cardiac output. HCTZ still lowered BP following treatment of NCC KO on salt restricted diet with paxilline (8 mg/kg, i.p.), a BK channel blocker, and in BK KO and BK/NCC dKO mice on salt restricted diet. In aortic rings from NCC KO mice on normal and low salt diet, HCTZ did not alter and minimally decreased maximal phenylephrine contraction, respectively, while contractile sensitivity remained unchanged. These results demonstrate 1) the non-diuretic hypotensive effects of thiazides are augmented with volume depletion and 2) that the BP reduction is likely the result of HCTZ inhibition of vasoconstriction through a pathway dependent on factors present in vivo, is unrelated to BK channel activation, and involves processes associated with intravascular volume depletion.
包括氢氯噻嗪(HCTZ)在内的噻嗪类衍生物是轻度至中度高血压最常见的治疗药物。噻嗪类药物最初通过抑制肾脏的钠-氯共转运体(NCC)来增强利尿作用。然而,慢性容量耗竭和利尿作用很小,而噻嗪类药物在维持血压降低(BP)的同时。因此,有人提出噻嗪类药物具有血管舒张作用,可能是通过血管平滑肌中的钙激活钾(BK)通道实现的。本研究确定了盐限制或盐耗竭诱导的容量耗竭在NCC基因敲除小鼠中对HCTZ非利尿性降压作用的作用。HCTZ(20mg/kg皮下注射)可降低血压:1)在盐限制饮食的NCC基因敲除小鼠中,但正常饮食的小鼠中则不然;2)在容量耗竭的pendrin/NCC双基因敲除小鼠中,但在容量复苏的小鼠中则不然;血压降低时,盐排泄没有任何增加,心输出量也没有减少。在用BK通道阻滞剂帕吉林(8mg/kg,腹腔注射)治疗盐限制饮食的NCC基因敲除小鼠后,以及在盐限制饮食的BK基因敲除和BK/NCC双基因敲除小鼠中,HCTZ仍能降低血压。在正常和低盐饮食的NCC基因敲除小鼠的主动脉环中,HCTZ分别没有改变和最小程度地降低了去氧肾上腺素最大收缩,而收缩敏感性保持不变。这些结果表明:1)噻嗪类药物的非利尿性降压作用随着容量耗竭而增强;2)血压降低可能是HCTZ通过依赖体内存在的因素的途径抑制血管收缩的结果,与BK通道激活无关,并且涉及与血管内容量耗竭相关的过程。